Comprehensive Assessment of Neurodegeneration and Dementia

Key facts

Sponsor

McGill University

Principal Investigator

Michael Borrie, MD, M.D

Western University

Enrollment

1573 enrolled

Eligibility

50-90 years · All sexes

Timeline

2016 – 2029

Study locations (19)

• University of Calgary, Calgary, Alberta, Canada
• University of Alberta Hospital, Edmonton, Alberta, Canada
• Djavad Mowafaghian Centre for Brain Health, Vancouver, British Columbia, Canada
• Island Health, Victoria, British Columbia, Canada
• Veteran's Memorial Building, Halifax, Nova Scotia, Canada
• Hamilton General Hospital, Hamilton, Ontario, Canada
• St. Joseph's Health Care London, London, Ontario, Canada
• Gait and Brain Lab, London, Ontario, Canada
• Bruyère Research Institute, Ottawa, Ontario, Canada
• Kawartha Centre, Peterborough, Ontario, Canada
• Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
• University Health Network Memory Clinic, Toronto, Ontario, Canada
• Baycrest Clinical Unit, Toronto, Ontario, Canada
• University of Waterloo, Waterloo, Ontario, Canada
• Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
• +4 more locations on ClinicalTrials.gov

Collaborators

Canadian Institutes of Health Research (CIHR) · Alzheimer Society of Canada · Sanofi · New Brunswick Health Research Foundation · Saskatchewan Health Research Foundation · Michael Smith Foundation for Health Research · Nova Scotia Health Research Foundation · Eli Lilly and Company · Canadian Nurses Foundation (CNF) · Ontario Brain Institute · Pfizer · Canadian Consortium on Neurodegeneration in Aging

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Frontotemporal dementia

Additional recruiting or active studies for the same condition.

• ENROLLING BY INVITATIONNCT07239843
  Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders
  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
• RECRUITINGNCT06856850
  Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches
  Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
• RECRUITINGNCT06803784
  Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders
  Neuromed IRCCS
• ENROLLING BY INVITATIONNCT07234851
  Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs.
  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
• ACTIVE NOT RECRUITINGNANCT06768996
  Music, Social Attention, and Dementia
  University of California, San Francisco
• RECRUITINGNANCT06668610
  A Multifocal TDCS-EEG Protocol for Improving Symptoms of Mild Cognitive Impairment and Early Dementia
  University of Campania Luigi Vanvitelli
• RECRUITINGEARLY PHASE1NCT06511752
  Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia
  University of Texas at Austin
• RECRUITINGNCT06528964
  Proteinopathies Expression in Skin of Neurodegenerative Disorders
  Universidad Autonoma de San Luis Potosí

See all trials for Frontotemporal dementia →